logo
Select company
Select metric
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - FCF/OCF Historical data
DateFree Cash FlowFree Cash Flow to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ -43.57M0%$ -23.18M
3/31/2025$ -82.24M0%$ -55.46M
12/31/2024$ -96.48M0%$ -70.58M
9/30/2024$ -96.71M0%$ -78.76M
6/30/2024$ -100.33M0%$ -89.97M
3/31/2024$ -113.29M0%$ -107.32M
12/31/2023$ -99.19M0%$ -92.5M
9/30/2023$ -112.21M0%$ -103.15M
6/30/2023$ -106.21M0%$ -97.09M
3/31/2023$ -101.79M0%$ -94.56M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) FCF/OCF stands at 79.61%.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average FCF/OCF has been 79.61%.
  • The median FCF/OCF for ENANTA PHARMACEUTICALS INC during this period was 79.61%
  • ENANTA PHARMACEUTICALS INC reached its highest FCF/OCF over the past 5 years at 79.61%.
  • The lowest FCF/OCF recorded by ENANTA PHARMACEUTICALS INC in the same timeframe 79.61%

ENANTA PHARMACEUTICALS INC's FCF/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF/OCF Benchmarks
CompanyFCF/OCF
THTX : THERATECHNOLOGIES INC 99.84%BDTX : BLACK DIAMOND THERAPEUTICS INC 100.44%PLX : PROTALIX BIOTHERAPEUTICS INC -ALEC : ALECTOR INC -SGMO : SANGAMO THERAPEUTICS INC -CSBR : CHAMPIONS ONCOLOGY INC 94.33%SPRO : SPERO THERAPEUTICS INC -CCCC : C4 THERAPEUTICS INC -TRDA : ENTRADA THERAPEUTICS INC -CELU : CELULARITY INC -

Definition of Free Cash Flow to Operating Cash Flow

[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
FCF / CF - Operations
(=) FCF/OCF
FCF/OCF for ENANTA PHARMACEUTICALS INC is calculated as follows: FCF [ $ 5.64M ] / CF - Operations [ $ 7.09M ]
(=) FCF/OCF [ 79.61% ]

ENTA - Free Cash Flow to Operating Cash Flow, Last 5 years

79.61%

Minimum

Sep 30, 2020

79.61%

Maximum

Sep 30, 2020

79.61%

Average

79.61%

Median

FCF/OCF Benchmark Analysis

The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.45% with a standard deviation of 29.09%.
The following table provides additional summary stats:
FCF/OCF in the Market:
filtered constituents2.51K
min-23%
max171.58%
average71.45%
median80.76%
std29.09%